专题：Inflammatory Biomarkers in Disease Prognosis

This cluster of papers explores the intricate relationship between inflammation and cancer, focusing on the role of immunity, systemic inflammatory response, platelets, and various prognostic markers in cancer development, progression, and treatment effectiveness. It delves into the mechanisms of inflammation-induced cancer, the impact of platelets on metastasis, and the potential of inflammatory pathways as therapeutic targets.
最新文献
Myeloid-derived suppressor cells in cancer and cancer therapy

review Full Text OpenAlex

Insights into the Neutrophil-to-Lymphocyte Ratio and the Platelet-to-Lymphocyte Ratio as Predictors for the Length of Stay and Readmission in Chronic Heart Failure Patients

article Full Text OpenAlex

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Dysphagia Severity and Quality of Life in Nasopharyngeal Cancer Patients after Intensity Modulated Radiotherapy (IMRT)

article Full Text OpenAlex

Prognostic value of neutrophil-to-monocyte/lymphocyte ratio for 28-day mortality in ICU sepsis patients: a retrospective cohort study

article Full Text OpenAlex

The association between Behçet disease activity and elevated systemic immune–inflammation index: A retrospective observational study in a tertiary care hospital

article Full Text OpenAlex

Monocyte/lymphocyte ratio as a risk factor of cardiovascular and all-cause mortality in coronary artery disease with low-density lipoprotein cholesterol levels below 1.4 mmol/L: A large longitudinal multicenter study

article Full Text OpenAlex

Prognostic roles of neutrophil–lymphocyte, monocyte-lymphocyte and platelet-lymphocyte ratios for long-term all-cause mortality in heart failure

article Full Text OpenAlex

Prognostic value of neutrophil to lymphocyte ratio in patients with advanced pancreatic ductal adenocarcinoma treated with systemic chemotherapy

article Full Text OpenAlex

CT-based whole lung radiomics nomogram for identification of PRISm from non-COPD subjects

article Full Text OpenAlex

Integration of clinical and blood parameters in risk prognostication for patients receiving immunochemotherapy for extensive stage small cell lung cancer: real-world data from two centers

article Full Text OpenAlex

近5年高被引文献
Pyroptosis: mechanisms and diseases

review Full Text OpenAlex 2063 FWCI153.02837835

Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases

review Full Text OpenAlex 783 FWCI116.6393563

Neutrophil-to-lymphocyte ratio, past, present and future perspectives

article Full Text OpenAlex 763 FWCI52.62540978

Neutrophils in cancer: heterogeneous and multifaceted

review Full Text OpenAlex 697 FWCI57.18472704

Systemic inflammation markers and cancer incidence in the UK Biobank

article Full Text OpenAlex 439 FWCI31.23978509

ROS-triggered endothelial cell death mechanisms: Focus on pyroptosis, parthanatos, and ferroptosis

review Full Text OpenAlex 427 FWCI52.4274613

Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors

article Full Text OpenAlex 420 FWCI36.69102275

Inflammation-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients

review Full Text OpenAlex 400 FWCI29.03832372

Neutrophil-to-lymphocyte ratio and mortality in the United States general population

article Full Text OpenAlex 392 FWCI31.0301221

Systemic Immune Inflammation Index (SII), System Inflammation Response Index (SIRI) and Risk of All-Cause Mortality and Cardiovascular Mortality: A 20-Year Follow-Up Cohort Study of 42,875 US Adults

article Full Text OpenAlex 391 FWCI92.90043738